BBOTVSRFL• 3 Months (Normalized)
BBOT vs RFL (BridgeBio Oncology Therapeutics Inc. vs Rafael Holdings Inc.)
Showing Closing Date Range from Jul 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-53.75%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
RFL Performance $1.54
-44.2%
Rafael Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin RFL LEADS
-9.55 pts
RFL outperforming by 9.55 percentage points
BBOTRFL
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT RFL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | BBOT Price | BBOT Gain (%) | RFL Price | RFL Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -53.75% | $1.54 | -44.20% | -9.55% |
| Sep 30, 2026 | $4.10 | -51.25% | $1.32 | -52.17% | +0.92% |
| Sep 29, 2026 | $3.92 | -53.39% | $2.03 | -26.45% | -26.94% |
| Sep 28, 2026 | $3.81 | -54.70% | $2.02 | -26.81% | -27.89% |
| Sep 25, 2026 | $3.95 | -53.03% | $1.94 | -29.71% | -23.32% |
| Sep 24, 2026 | $3.99 | -52.56% | $1.91 | -30.80% | -21.76% |
| Sep 23, 2026 | $4.16 | -50.54% | $2.02 | -26.81% | -23.73% |
| Sep 22, 2026 | $4.66 | -44.59% | $2.00 | -27.54% | -17.05% |
| Sep 21, 2026 | $4.66 | -44.59% | $2.00 | -27.54% | -17.05% |
| Sep 18, 2026 | $4.77 | -43.28% | $2.05 | -25.72% | -17.56% |
| Sep 17, 2026 | $4.89 | -41.85% | $2.06 | -25.36% | -16.49% |
| Sep 16, 2026 | $4.76 | -43.40% | $2.06 | -25.36% | -18.04% |
| Sep 15, 2026 | $4.88 | -41.97% | $2.14 | -22.46% | -19.51% |
| Sep 14, 2026 | $5.05 | -39.95% | $2.18 | -21.01% | -18.94% |
| Sep 11, 2026 | $4.95 | -41.14% | $2.28 | -17.39% | -23.75% |
Page 1 of 5